Healthcare IT News Asia Pacific Announces Thai Edition

Food and Healthcare Press Releases Monday February 4, 2019 11:00
SINGAPORE--4 Feb--PRNewswire/InfoQuest
Following the official launch of the Asia Pacific regional edition of Healthcare IT News (HITN) in November 2018, HIMSS Asia Pacific today announced the launch of the Thai language edition of HITN.

HITN is the industry's authoritative source covering the people, policy, and technology driving next-generation healthcare. It focuses on news, features, analysis and decision content tied to healthcare information and technology. Key topics include analytics, artificial intelligence, cloud computing, EHR, government & policy, interoperability, patient engagement, population health, precision medicine, privacy & security, telehealth, and women in health IT.

HITN's global website generates on average 645,000 monthly page views from 292,000 unique monthly visitors.

"Thailand is known for its reputation as a medical tourism hub with its excellent private healthcare facilities and there are enormous opportunities for growth in terms of digital health. With the launch of the Thai edition of HITN, we hope that we can reach out to members of the Thai healthcare community more intimately, as well as offer local and international insights in healthcare trends and developments," says Simon Lin, Vice President APAC, HIMSS.

The Thai edition of HITN will be distributed weekly, with a relevant mix of local, regional and international news and analysis, says Dean Koh, HIMSS's APAC region editor. "The recent announcement of price controls on medical drugs, supplies and services in Thailand is something that we are watching with close interest, and we want to bring the latest developments and analysis to our readers."

About Healthcare IT News
Healthcare IT News is the industry's authoritative source covering the people, policy, and technology driving next-generation healthcare. www.healthcareitnews.com/asia-pacific.
About HIMSS

HIMSS is a global voice, advisor and thought leader of health transformation through health and information technology with a unique breadth and depth of expertise and capabilities to improve the quality, safety, and efficiency of health, healthcare and care outcomes. HIMSS designs and leverages key data assets, predictive models and tools to advise global leaders, stakeholders and influencers of best practices in health and information technology, so they have the right information at the point of decision. Through its health and information technology network of over 1 million experts, over 200 knowledge exchanges and collaborations, including 60,000-plus members, HIMSS drives innovative, forward thinking around best uses of technology in support of better connected care, improved population health and low cost of care. HIMSS is a not-for-profit, headquartered in Chicago, Illinois with additional offices in North America, Europe, United Kingdom and Asia.


Latest Press Release

Mallinckrodt Announces Interim Analysis Results for Therakos(R) Platform Phase 3 Clinical Trial in Treatment of Pediatric Patients with Steroid Refractory Acute Graft-versus-Host Disease

-- Overall response rate exceeded specified study midpoint target (n=25); company elects to discontinue further patient enrollment as allowed by protocol -- Mallinckrodt plc (NYSE:MNK), a leading global specialty pharmaceutical company, today announced...

Takeda, Microsoft and EURORDIS release report with action plan to help rare disease community shorten the diagnostic odyssey

- Global Commission's recommendations focus on three solution pathways that leverage technology to address key elements of the rare disease diagnostic odyssey - Rare diseases remain undiagnosed as patients struggle to navigate complex health systems to...

Pivotal Phase III Data for BAVENCIO(R) (avelumab) Plus INLYTA(R) (axitinib) in Advanced Renal Cell Carcinoma Published in the New England Journal of Medicine

- JAVELIN Renal 101 shows significant improvement in progression-free survival with a hazard ratio of 0.69 in patients regardless of PD-L1 expression - US FDA has granted Priority Review to BAVENCIO plus INLYTA for patients with advanced renal cell...

ISABS เตรียมจัดการประชุมว่าด้วยการแพทย์ส่วนบุคคลที่โครเอเชีย พร้อมเชิญเจ้าของรางวัลโนเบลร่วมบรรยาย

International Society for Applied Biological Sciences (ISABS) ร่วมกับ Mayo Clinic และ St. Catherine Hospital เตรียมจัดการประชุม "ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine" ครั้งที่ 11...

ISABS: Personalized Medicine Conference With Nobel Laureates to Be Held in Split, Croatia

International Society for Applied Biological Sciences (ISABS), Mayo Clinic and St. Catherine Hospital are organizing "11th ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine"(http://www.isabs.net)...

Related Topics